Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Total Hip Arthroplasty Outcomes
Total Hip Arthroplasty ACS NSQIP Outcomes
January 1, 2020 – December 31, 2020
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total hip arthroplasty ACS NSQIP performance benchmarked against 490 participating sites.
|Total Hip Arthroplasty (490 sites)||N||Observed||Expected|
|30 Day Mortality||337||0.59%||0.69%|
|30 Day Morbidity||337||5.04%||4.48%|
|Deep Vein Thrombosis (DVT) / Pulmonary Embolus||337||0.30%||0.77%|
|Urinary Tract Infection (UTI)||337||0.89%||0.65%|
|Surgical Site Infection (SSI)||336||1.19%||1.88%|
|Return to Operating Room (ROR)||337||3.86%||3.12%|
American College of Surgeons National Surgical Quality Improvement Program, 2021.
ACS NSQIP® Semiannual Report July 8, 2021, Chicago: American College of Surgeons.